Study Summary
This trial is testing whether a surgery to remove as much of the cancer as possible, followed by a heated chemotherapy treatment, is a safe and effective treatment for ovarian, fallopian tube, and primary peritoneal cancer.
- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma
- Stage III Ovarian Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: Baseline, 4 weeks post-operative, upon completion of systemic chemotherapy, and years 1, 2, 3, 4, & 5
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
CRS with adjuvant IV/IP chemotherapy
1 of 2
CRS/HIPEC with adjuvant IV chemotherapy
1 of 2
Active Control
Experimental Treatment
48 Total Participants · 2 Treatment Groups
Primary Treatment: Hyperthermic intraperitoneal chemotherapy · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · Female Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Does the FDA recognize Hyperthermic intraperitoneal chemotherapy as an accepted treatment?
"Hyperthermic intraperitoneal chemotherapy is at a Phase 2, meaning that while there is safety data, there is no information yet on whether it works. Our team rates it as a 2." - Anonymous Online Contributor
Can new patients still join this clinical trial?
"Yes, this study is still recruiting patients as of 8/30/2022 according to the clinicaltrials.gov website. The trial was initially posted on 4/1/2014." - Anonymous Online Contributor
Does this experiment have an age limit? Can elderly persons participate?
"The age criteria for this study stipulate that patients must be over 18 but under 80 years old." - Anonymous Online Contributor
Who meets the eligibility requirements for this research?
"Eligibility criteria for this ovarian cancer clinical trial are being between 18-80 years old. They aim to recruit 48 patients in total." - Anonymous Online Contributor
What is the most common reason that patients receive hyperthermic intraperitoneal chemotherapy?
"Hyperthermic intraperitoneal chemotherapy is a well-known treatment for advanced endometrial cancer. Other conditions that this method can be used to treat include melanoma, neoplasm metastasis, lymphoma, and non-hodgkin." - Anonymous Online Contributor
How many people are participating in this clinical trial?
"That is correct, the clinical trial referenced is actively recruiting patients according to information found on clinicaltrials.gov. The original posting was on April 1st, 2014 with the most recent update being on August 30th, 2022. There is a need for 48 patients at a single location." - Anonymous Online Contributor